Title: Laboratory of Molecular Technology LMT
1Laboratory of Molecular Technology (LMT)
915 Tollhouse Road, Frederick, MD
http//web.ncifcrf.gov/rtp/labs/LMT/
2- Complete genomics facility
- Technology platforms
- Genomic analysis
- Molecular interactions
- Gene expression
- Transcription
- Post-transcription
- Translation
- Post translation
3- Access and develop new technologies
- Availability to NCI researchers
- Core services
- Collaborations
- Apply to independent research programs
- Ovarian development
- Ovarian cancer
- Prostate cancer
4LMT Core Services
- Sequencing
- standard
- high-throughput
- Microarray
- Genotyping
- Custom automation
- Oligonucleotide synthesis
- Molecular diagnostics
5LMT Sequencing Core
4 ABI 377 slab-gel sequencers
3 ABI 3700 capillary sequencers
- Sequencing in tube, 96-well, or 384-well formats
- Data analysis
Current output 25,000 sequences / month (95
of theoretical capacity)
6GEOSPIZA INC.Software for Molecular Biology
7LMT Microarray Core
2 Axon GenePix 4000A microarray scanners
2 BioRobotics MicroGrid II microarray spotting
robots
- 400 Incyte GEM II mouse arrays distributed /
month - other libraries
- assistance with study design
- assistance with data analysis
- Affymetrix Workstation
8LMT Molecular Diagnostics Core
- CLIA certified
- Viral detection
- DNA quantitation
- Mouse speciation
- Mycoplasma detection
- Mutation detection
9LMT Oligonucleotide Synthesis Core
- Instrumentation
- 2 ABI 394 oligonucleotide synthesizers
- 1 ABI Ezpedite oligonucleotide synthesizer
- 1 HP 1015 HPLC
- Services offered
- standard oligonucleotides
- modified oligonucleotides
- PNA oligonucleotides
- HPLC purification
- Gel-purification
- Output 3500 oligonucleotides/month
10Other LMT Core Services
- Genotyping
- coming soon (July 2002)
- Custom automation
- automated colony picking
- re-array
- high density filter arrays (colony and DNA)
- automated process development
- custom automation software development
11(No Transcript)
12LMT Research and Development
- Currently ongoing RD at LMT (independent and
collaborative) - expression profiling
- ovarian metastasis
- mouse ovarian development
- rat ovarian development
- mouse model of ovarian cancer
- p27 and prostate tumor regression
- prostate tumor prognostics and ethnicity
- caveolin 1 function during colon cancer
development - immune response
13LMT Research and Development
- Currently ongoing RD at LMT (independent and
collaborative) - microarray-based monoclonal antibody screening
and selection - sera microarrays
- DNA methylation / gene expression (NCI 60
cell-line panel) - electronic microarray development (Nanogen
Corporation) - high-throughput monoclonal antibody production
- multiplex analysis
- electronic stringency
- electronic addressing
- universal detection
- primer picking software
14LMT Research and Development
- Currently ongoing RD at LMT (independent and
collaborative) - functional SNP association and prostate tumor
prognostics/ethnicity - automated molecular screening
- high-throughput LOH analysis
- automated process development (Beckman Coulter)
- automated, high-throughput ABI 7900 genotyping
- universal detection system for ABI 7900
genotyping - virtual 2-D gel software
- real-time PCR primer picking software
- ABI 7900 genotyping primer picking software
- haplotype generation software
15LMT Research and Development
- RD at LMT (in development or planned)
- whole genome yeast 2-hybrid system
- DNA methylation changes during mouse ovarian
development - prostate tumor gene expressionLOH events
16- Collaborators
- NCI
- J. Weinstein
- M. Nickerson
- R. Bedigian
- J. Sharp
- J. Coffin
- S. OBrien
- M. Dean
- B. Gold
- J. Slattery
- Johns Hopkins Medical Center
- A. Feinberg
- University of Chile
- J. Allende
- A. Quest
- C. Cortes
- LSU Medical Center
- W. Rayford
LMT Group Leaders Microarray-Lisa
Gangi Genomics-Shirley Tsang Diagnostics-Kris
Pike Oligonucleotide synthesis- Leo
Lee Sequencing and Automation-Lynn
Rasmussen High-throughput-Claudia
Stewart Standard-John Elser Automation-Casey
Frankenberger